220 related articles for article (PubMed ID: 29504543)
1. Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.
Gauthier S; Ng KP; Pascoal TA; Zhang H; Rosa-Neto P
J Alzheimers Dis; 2018; 64(s1):S23-S31. PubMed ID: 29504543
[TBL] [Abstract][Full Text] [Related]
2. Early Diagnosis and Targeted Treatment Strategy for Improved Therapeutic Outcomes in Alzheimer's Disease.
Guest FL; Rahmoune H; Guest PC
Adv Exp Med Biol; 2020; 1260():175-191. PubMed ID: 32304035
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers and Precision Medicine in Alzheimer's Disease.
Sagar R; Pathak P; Pandur B; Kim SJ; Li J; Mahairaki V
Adv Exp Med Biol; 2021; 1339():403-408. PubMed ID: 35023132
[TBL] [Abstract][Full Text] [Related]
4. Personalized medicine in Alzheimer's disease and depression.
Souslova T; Marple TC; Spiekerman AM; Mohammad AA
Contemp Clin Trials; 2013 Nov; 36(2):616-23. PubMed ID: 23816492
[TBL] [Abstract][Full Text] [Related]
5. Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment.
De Matteis L; Martín-Rapún R; de la Fuente JM
Curr Med Chem; 2018; 25(35):4602-4615. PubMed ID: 29022501
[TBL] [Abstract][Full Text] [Related]
6. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
Knopman DS; Haeberlein SB; Carrillo MC; Hendrix JA; Kerchner G; Margolin R; Maruff P; Miller DS; Tong G; Tome MB; Murray ME; Nelson PT; Sano M; Mattsson N; Sultzer DL; Montine TJ; Jack CR; Kolb H; Petersen RC; Vemuri P; Canniere MZ; Schneider JA; Resnick SM; Romano G; van Harten AC; Wolk DA; Bain LJ; Siemers E
Alzheimers Dement; 2018 Apr; 14(4):563-575. PubMed ID: 29653607
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: The next frontier-Special Report 2017.
Karlawish J; Jack CR; Rocca WA; Snyder HM; Carrillo MC
Alzheimers Dement; 2017 Apr; 13(4):374-380. PubMed ID: 28314660
[TBL] [Abstract][Full Text] [Related]
8. Neuroinflammation in Alzheimer's disease; A source of heterogeneity and target for personalized therapy.
Latta CH; Brothers HM; Wilcock DM
Neuroscience; 2015 Aug; 302():103-11. PubMed ID: 25286385
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease.
Scheltens P; Blennow K; Breteler MM; de Strooper B; Frisoni GB; Salloway S; Van der Flier WM
Lancet; 2016 Jul; 388(10043):505-17. PubMed ID: 26921134
[TBL] [Abstract][Full Text] [Related]
10. Impact of the biological definition of Alzheimer's disease using amyloid, tau and neurodegeneration (ATN): what about the role of vascular changes, inflammation, Lewy body pathology?
Gauthier S; Zhang H; Ng KP; Pascoal TA; Rosa-Neto P
Transl Neurodegener; 2018; 7():12. PubMed ID: 29876101
[TBL] [Abstract][Full Text] [Related]
11. Delineating Alzheimer's disease progression with MGAT3, a biomarker for improved prognosis and personalized therapy.
Fiala M; Porter V
Biomark Med; 2011 Oct; 5(5):645-7. PubMed ID: 22003913
[No Abstract] [Full Text] [Related]
12. The application of lipidomics to biomarker research and pathomechanisms in Alzheimer's disease.
Wong MW; Braidy N; Poljak A; Sachdev PS
Curr Opin Psychiatry; 2017 Mar; 30(2):136-144. PubMed ID: 28002106
[TBL] [Abstract][Full Text] [Related]
13. Revolution of Alzheimer Precision Neurology. Passageway of Systems Biology and Neurophysiology.
Hampel H; Toschi N; Babiloni C; Baldacci F; Black KL; Bokde ALW; Bun RS; Cacciola F; Cavedo E; Chiesa PA; Colliot O; Coman CM; Dubois B; Duggento A; Durrleman S; Ferretti MT; George N; Genthon R; Habert MO; Herholz K; Koronyo Y; Koronyo-Hamaoui M; Lamari F; Langevin T; Lehéricy S; Lorenceau J; Neri C; Nisticò R; Nyasse-Messene F; Ritchie C; Rossi S; Santarnecchi E; Sporns O; Verdooner SR; Vergallo A; Villain N; Younesi E; Garaci F; Lista S;
J Alzheimers Dis; 2018; 64(s1):S47-S105. PubMed ID: 29562524
[TBL] [Abstract][Full Text] [Related]
14. Early detection and personalized medicine: Future strategies against Alzheimer's disease.
Di Meco A; Vassar R
Prog Mol Biol Transl Sci; 2021; 177():157-173. PubMed ID: 33453940
[TBL] [Abstract][Full Text] [Related]
15. The path to next-generation disease-modifying immunomodulatory combination therapies in Alzheimer's disease.
Sarazin M; Lagarde J; El Haddad I; de Souza LC; Bellier B; Potier MC; Bottlaender M; Dorothée G
Nat Aging; 2024 Jun; 4(6):761-770. PubMed ID: 38839924
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers and imaging: physics and chemistry for noninvasive analyses.
Moyer BR; Barrett JA
Bioanalysis; 2009 May; 1(2):321-56. PubMed ID: 21083171
[TBL] [Abstract][Full Text] [Related]
17. Developing Treatments for Alzheimer's and Related Disorders with Precision Medicine: A Vision.
Avramopoulos D; Kapogiannis D; Leoutsakos JM; Lyketsos CG; Mahairaki V; Nowrangi M; Oishi K; Oh ES; Rosenberg PB; Samus Q; Smith GS; Witwer K; Yasar S; Zandi PP
Adv Exp Med Biol; 2021; 1339():395-402. PubMed ID: 35023131
[TBL] [Abstract][Full Text] [Related]
18. Recent advances in cerebrospinal fluid biomarkers for the detection of preclinical Alzheimer's disease.
Kulic L; Unschuld PG
Curr Opin Neurol; 2016 Dec; 29(6):749-755. PubMed ID: 27805971
[TBL] [Abstract][Full Text] [Related]
19. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
Perani D; Cerami C; Caminiti SP; Santangelo R; Coppi E; Ferrari L; Pinto P; Passerini G; Falini A; Iannaccone S; Cappa SF; Comi G; Gianolli L; Magnani G
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):499-508. PubMed ID: 26341365
[TBL] [Abstract][Full Text] [Related]
20. Systems Biology Methods for Alzheimer's Disease Research Toward Molecular Signatures, Subtypes, and Stages and Precision Medicine: Application in Cohort Studies and Trials.
Castrillo JI; Lista S; Hampel H; Ritchie CW
Methods Mol Biol; 2018; 1750():31-66. PubMed ID: 29512064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
